http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012114665-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50eb752940fa4aa36756a6bc9f6f3504
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ecb5f9dcc345d2c40eb1948ffc07243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a3292b2c7af02a969cc607d8444bfe97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19d9529c3ee3f9fbd7ad8f0b9880a679
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2875
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
filingDate 2009-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c1176f327c37446fac23e1520226bd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1aed5c262c7a84f25646808f7e805d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ef8cda62653893b49e316bd2faf8a31
publicationDate 2012-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2012114665-A1
titleOfInvention Human antibodies to human rankl
abstract Isolated human antibodies or antigen-binding fragments thereof, which specifically bind to human RANKL and block hRANKL binding to a RANK receptor, are provided. The antibodies are useful in preventing or treating disorders and/or diseases, which are associated with RANKL/RANK interactions, including bone disorders or cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130129866-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11370842-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109890845-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10806786-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7246306-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013176469-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170103767-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102516712-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019028190-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016075221-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020500836-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101593271-B1
priorityDate 2008-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7534868-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7993646-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23675317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226504035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399382
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226501532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226506143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94270
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22827360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22809234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9907842
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136160036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6713579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395317
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395985

Total number of triples: 84.